Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces updates to NIH terminology, including a transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T21:59:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:14:50.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:13:38.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error page, with the site header and footer visible, indicating restricted access to the content.
    Difference
    18%
    Check dated 2026-09-19T22:20:29.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now reflects a new site revision (v3.6.6) replacing the previous version (v3.6.5). This appears to be a minor maintenance/update to the site interface and does not affect the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:16:37.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4, as a software version update. It does not modify the study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T16:53:56.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.